Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5084763012 | Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5084764018 | Aluminium hydroxide- and magnesium hydroxide- and oxetacaine-containing product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5084765017 | Product containing aluminium hydroxide and magnesium hydroxide and oxetacaine in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | a une forme pharmaceutique (attribut) | forme orale | true | Inferred relationship | Some | ||
| Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | Plays role | Laxative therapeutic role | true | Inferred relationship | Some | ||
| Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | a pour principe actif (attribut) | Oxethazaine | true | Inferred relationship | Some | 1 | |
| Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | a pour principe actif (attribut) | Magnesium hydroxide (substance) | true | Inferred relationship | Some | 2 | |
| Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | est un(e) (attribut) | Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product | true | Inferred relationship | Some | ||
| Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | est un(e) (attribut) | Product containing aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | a pour principe actif (attribut) | Aluminium hydroxide (substance) | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aluminum hydroxide and magnesium hydroxide and oxethazaine only product in oral dose form | est un(e) (attribut) | True | Aluminum hydroxide- and magnesium hydroxide- and oxethazaine-containing product in oral dose form | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR